Cwm, LLC Teva Pharmaceutical Industries LTD Transaction History

Cwm, LLC

$21.2 Billion
Q2 2024

A detailed history of Cwm, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cwm, LLC holds 4,066 shares of TEVA stock, worth $72,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,066

Previous 3,671 10.76%

Holding current value

$72,659

Previous $52,000 26.92%

% of portfolio

0.0%

Previous 0.0%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	BUY	$12.78 - $17.4 $5,048 - $6,872	395 Added 10.76%	4,066 $66,000
Q1 2024 Apr 05, 2024	BUY	$10.67 - $14.43 $4,481 - $6,060	420 Added 12.92%	3,671 $52,000
Q4 2023 Feb 01, 2024	BUY	$8.12 - $10.63 $2,939 - $3,848	362 Added 12.53%	3,251 $34,000
Q3 2023 Oct 11, 2023	BUY	$7.48 - $10.7 $6,702 - $9,587	896 Added 44.96%	2,889 $29,000
Q2 2023 Aug 03, 2023	SELL	$7.2 - $9.47 $684 - $899	-95 Reduced 4.55%	1,993 $15,000
Q1 2023 Apr 28, 2023	SELL	$8.36 - $11.37 $852 - $1,159	-102 Reduced 4.66%	2,088 $18,000
Q4 2022 Feb 01, 2023	BUY	$7.95 - $9.48 $1,295 - $1,545	163 Added 8.04%	2,190 $20,000
Q3 2022 Oct 27, 2022	BUY	$6.86 - $11.95 $1,399 - $2,437	204 Added 11.19%	2,027 $16,000
Q2 2022 Jul 28, 2022	BUY	$7.38 - $10.4 $1,476 - $2,080	200 Added 12.32%	1,823 $14,000
Q1 2022 Apr 21, 2022	SELL	$7.33 - $9.39 $1,077 - $1,380	-147 Reduced 8.31%	1,623 $15,000
Q4 2021 Jan 31, 2022	BUY	$7.9 - $10.19 $5,253 - $6,776	665 Added 60.18%	1,770 $14,000
Q1 2021 Sep 15, 2021	SELL	$10.34 - $12.81 $6,204 - $7,686	-600 Reduced 35.19%	1,105 $11,000
Q1 2021 Apr 27, 2021	BUY	$10.34 - $12.81 $6,204 - $7,686	600 Added 54.3%	1,705 $20,000
Q4 2020 Sep 15, 2021	SELL	$8.61 - $11.04 $172 - $220	-20 Reduced 1.78%	1,105 $11,000
Q4 2020 Jan 27, 2021	BUY	$8.61 - $11.04 $172 - $220	20 Added 1.81%	1,125 $11,000
Q3 2020 Sep 15, 2021	SELL	$8.57 - $12.69 $2,956 - $4,378	-345 Reduced 23.79%	1,105 $11,000
Q3 2020 Oct 19, 2020	BUY	$8.57 - $12.69 $2,956 - $4,378	345 Added 31.22%	1,450 $13,000
Q2 2020 Sep 15, 2021	SELL	$8.12 - $13.12 $3,759 - $6,074	-463 Reduced 29.53%	1,105 $11,000
Q2 2020 Jul 22, 2020	BUY	$8.12 - $13.12 $3,759 - $6,074	463 Added 41.9%	1,568 $19,000
Q1 2020 Sep 15, 2021	SELL	$6.69 - $13.45 $7,573 - $15,225	-1,132 Reduced 50.6%	1,105 $11,000
Q1 2020 Apr 28, 2020	BUY	$6.69 - $13.45 $7,573 - $15,225	1,132 Added 102.44%	2,237 $20,000
Q4 2019 Sep 14, 2021	BUY	$6.53 - $10.72 $156 - $257	24 Added 2.22%	1,105 $11,000
Q4 2019 Jan 27, 2020	SELL	$6.53 - $10.72 $156 - $257	-24 Reduced 2.17%	1,081 $11,000
Q3 2019 Sep 14, 2021	SELL	$6.16 - $9.6 $7,465 - $11,635	-1,212 Reduced 52.31%	1,105 $11,000
Q3 2019 Oct 22, 2019	BUY	$6.16 - $9.6 $7,465 - $11,635	1,212 Added 109.68%	2,317 $16,000
Q2 2019 Sep 14, 2021	SELL	$8.12 - $15.72 $11,619 - $22,495	-1,431 Reduced 56.43%	1,105 $11,000
Q2 2019 Jul 31, 2019	BUY	$8.12 - $15.72 $11,619 - $22,495	1,431 Added 129.5%	2,536 $23,000
Q1 2019 Sep 02, 2021	SELL	$15.58 - $20.01 $22,294 - $28,634	-1,431 Reduced 56.43%	1,105 $0
Q1 2019 Apr 22, 2019	SELL	$15.58 - $20.01 $77,931 - $100,090	-5,002 Reduced 66.36%	2,536 $40,000
Q4 2018 Jan 25, 2019	BUY	$14.59 - $23.84 $18,033 - $29,466	1,236 Added 19.61%	7,538 $116,000
Q3 2018 Oct 29, 2018	BUY	$21.06 - $25.65 $132,678 - $161,595	6,300 Added 315000.0%	6,302 $136,000
Q2 2018 Jul 31, 2018	SELL	$16.77 - $24.71 $1,056 - $1,556	-63 Reduced 96.92%	2 $0
Q1 2018 Apr 26, 2018	SELL	$16.68 - $22.07 $33 - $44	-2 Reduced 2.99%	65 $1,000
Q4 2017 Jan 16, 2018	SELL	$11.23 - $19.1 $3,369 - $5,730	-300 Reduced 81.74%	67 $1,000
Q3 2017 Oct 16, 2017	BUY	$15.41 - $32.17 $5,655 - $11,806	367	367 $6,000

Others Institutions Holding TEVA

# of Institutions

603

Shares Held

567M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account